AVROBIO, Inc. - stock earnings
AVRO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -8.8 million USD | ? USD |
| 2023Q3 | -21.6 million USD | ? USD |
| 2023Q2 | 67.5 million USD | ? USD |
| 2023Q1 | -24.1 million USD | ? USD |
| 2022Q4 | 32.6 million USD | ? USD |
| 2022Q3 | -22.8 million USD | ? USD |
| 2022Q2 | -28.3 million USD | ? USD |
| 2022Q1 | -30.2 million USD | ? USD |
| 2021Q4 | -28.2 million USD | ? USD |
| 2021Q3 | -32.6 million USD | ? USD |
| 2021Q2 | -31.4 million USD | ? USD |
| 2021Q1 | -26.9 million USD | ? USD |
| 2020Q4 | -28.1 million USD | ? USD |
| 2020Q3 | -36.8 million USD | ? USD |
| 2020Q2 | -28.8 million USD | ? USD |
| 2020Q1 | -26.0 million USD | ? USD |
| 2019Q4 | -22.7 million USD | ? USD |
| 2019Q3 | -17.1 million USD | ? USD |
| 2019Q2 | -16.1 million USD | ? USD |
| 2019Q1 | -17.1 million USD | ? USD |
| 2018Q4 | -16.0 million USD | ? USD |
| 2018Q3 | -11.6 million USD | ? USD |
| 2018Q2 | -10.5 million USD | ? USD |
| 2018Q1 | -8.2 million USD | ? USD |
| 2017Q4 | -7.6 million USD | ? USD |
| 2017Q3 | -6.4 million USD | ? USD |
| 2017Q2 | -2.5 million USD | ? USD |
| 2017Q1 | -2.1 million USD | ? USD |
| 2016Q4 | -4.7 million USD | ? USD |
AVRO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 12.2 million USD | ? USD |
| 2022 | -106.0 million USD | ? USD |
| 2021 | -117.7 million USD | ? USD |
| 2020 | -118.5 million USD | ? USD |
| 2019 | -72.1 million USD | ? USD |
| 2018 | -46.4 million USD | ? USD |
| 2017 | -18.6 million USD | ? USD |
| 2016 | -4.7 million USD | ? USD |
AVRO
Price: $1.22
52 week price:
Earnings Per Share: 0.27 USD
P/E Ratio: -13.20
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 362600
Market Capitalization: 58.8 million